ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 159 filers reported holding ARCELLX INC in Q4 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,036,447 | -20.6% | 453,641 | 0.0% | 5.24% | +7.4% |
| Q1 2024 | $31,550,732 | +23.5% | 453,641 | -1.5% | 4.88% | +22.8% |
| Q4 2023 | $25,554,476 | +16.0% | 460,441 | -25.0% | 3.98% | -41.0% |
| Q3 2023 | $22,027,485 | +13.5% | 613,921 | 0.0% | 6.74% | +97.9% |
| Q2 2023 | $19,412,182 | -30.7% | 613,921 | -32.5% | 3.41% | -41.2% |
| Q1 2023 | $28,024,129 | -5.5% | 909,579 | -5.0% | 5.79% | -9.3% |
| Q4 2022 | $29,661,832 | +48.5% | 957,451 | -10.0% | 6.38% | +37.1% |
| Q3 2022 | $19,968,000 | +3.8% | 1,063,835 | 0.0% | 4.66% | -9.2% |
| Q2 2022 | $19,234,000 | +37.2% | 1,063,835 | +6.4% | 5.13% | +45.3% |
| Q1 2022 | $14,016,000 | – | 999,727 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
| PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
| NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
| Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
| Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
| Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
| Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
| Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
| CAXTON CORP | 36,302 | $1,124,640 | 2.87% |